-
Why India’s budget needs to provide a boost to develop pharmaceutical sector
ExpressPharma
January 28, 2022
The COVID-19 pandemic has made many countries realise that the pharma sector is a crucial pillar of the economy, and everything must be done to make it self-resilient.
-
Third wave of COVID in India likely to peak in early Feb: Study
ExpressPharma
December 28, 2021
The third wave of the COVID-19 pandemic in India may peak by February 3, 2022, claims a modelling study by researchers at Indian Institute of Technology Kanpur.
-
Health Minister Mandaviya invites global investors from EXPO2020 to strengthen Make-in-India
expresspharma
December 14, 2021
India is leading in the development and production of COVID vaccine and helping the world in the fight against Corona: Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare...
-
Dr Jyotsna Dhawan joins DBT/India Alliance as CEO
expresspharma
December 07, 2021
She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
-
New opportunities for India in global API market
expresspharma
December 02, 2021
Active Pharmaceutical Ingredients (APIs) are the founding block of strategic architecture in the pharmaceutical value chain. More importantly, APIs provide therapeutic effect of a medicine and, are, therefore, the central innovation and, more often...
-
India ready to produce over five billion COVID vaccine doses by end of 2022: PM Modi
ExpressPharma
November 03, 2021
India is ready to produce over five billion COVID vaccine doses by the end of next year to help the world in the fight against the pandemic, Prime Minister Narendra Modi said at a G-20 Summit session...
-
India committed to supplying COVID-19 vaccines to other nations by year end
ExpressPharma
November 01, 2021
India is committed to supplying COVID-19 vaccines to other nations and such supplies are likely to begin by the end of this year, as the abundant production will not just meet domestic needs...
-
The growth of e-pharmacies in India
expresspharma
August 13, 2021
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these.
-
India authorises J&J’s Covid-19 vaccine for emergency use
pharmaceutical-technology
August 09, 2021
India has approved Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for emergency use, expanding the total number of anti-SARS-CoV-2 vaccines authorised in the country to five.
-
J&J single-dose COVID-19 vaccine gets approval for EUA in India
expresspharma
August 09, 2021
The single-shot vaccine in clinical trials proved to be 85 per cent effective in preventing COVID-19, and also showed protection against COVID-19 related hospitalisation and death.